News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,033 Results
Type
Article (47039)
Company Profile (320)
Press Release (713656)
Multimedia
Podcasts (130)
Webinars (24)
Section
Business (214641)
Career Advice (2194)
Deals (37203)
Drug Delivery (138)
Drug Development (85147)
Employer Resources (180)
FDA (17153)
Job Trends (15744)
News (363672)
Policy (34736)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2733)
Accelerated approval (42)
Adcomms (35)
Allergies (169)
Alliances (52375)
ALS (200)
Alzheimer's disease (1794)
Antibody-drug conjugate (ADC) (391)
Approvals (17450)
Artificial intelligence (627)
Autoimmune disease (232)
Automation (50)
Bankruptcy (376)
Best Places to Work (11942)
BIOSECURE Act (22)
Biosimilars (214)
Biotechnology (190)
Bladder cancer (182)
Brain cancer (68)
Breast cancer (707)
Cancer (5486)
Cardiovascular disease (475)
Career advice (1868)
Career pathing (42)
CAR-T (309)
CDC (57)
Celiac Disease (2)
Cell therapy (829)
Cervical cancer (42)
Clinical research (73141)
Collaboration (1971)
Company closure (4)
Compensation (1293)
Complete response letters (81)
COVID-19 (2830)
CRISPR (104)
C-suite (1014)
Cystic fibrosis (153)
Data (7143)
Decentralized trials (3)
Denatured (41)
Depression (158)
Dermatology (59)
Diabetes (566)
Diagnostics (7014)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (309)
Drug pricing (216)
Drug shortages (32)
Duchenne muscular dystrophy (269)
Earnings (94379)
Editorial (65)
Employer branding (21)
Employer resources (158)
Events (123984)
Executive appointments (1070)
FDA (20628)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1650)
Gene editing (218)
Generative AI (55)
Gene therapy (684)
GLP-1 (1084)
Government (4947)
Grass and pollen (7)
Guidances (397)
Healthcare (19445)
HIV (76)
Huntington's disease (53)
IgA nephropathy (95)
Immunology and inflammation (294)
Immuno-oncology (85)
Indications (158)
Infectious disease (3148)
Inflammatory bowel disease (215)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (280)
Interviews (339)
IPO (17127)
IRA (57)
Job creations (4133)
Job search strategy (1566)
JPM (65)
Kidney cancer (19)
Labor market (93)
Layoffs (598)
Leadership (39)
Legal (8546)
Liver cancer (101)
Longevity (29)
Lung cancer (741)
Lymphoma (411)
Machine learning (53)
Management (62)
Manufacturing (956)
MASH (185)
Medical device (14175)
Medtech (14254)
Mergers & acquisitions (21243)
Metabolic disorders (1469)
mRNA (191)
Multiple sclerosis (177)
NASH (19)
Neurodegenerative disease (400)
Neuropsychiatric disorders (105)
Neuroscience (3239)
Neurotech (1)
NextGen: Class of 2026 (6766)
Non-profit (4688)
Now hiring (73)
Obesity (698)
Opinion (313)
Ovarian cancer (187)
Pain (246)
Pancreatic cancer (260)
Parkinson's disease (352)
Partnered (34)
Patents (565)
Patient recruitment (603)
Peanut (64)
People (62244)
Pharmaceutical (88)
Pharmacy benefit managers (34)
Phase 1 (22727)
Phase 2 (32128)
Phase 3 (24069)
Pipeline (7203)
Policy (326)
Postmarket research (2757)
Preclinical (9677)
Press Release (68)
Prostate cancer (284)
Psychedelics (53)
Radiopharmaceuticals (311)
Rare diseases (1043)
Real estate (6424)
Recruiting (73)
Regulatory (26315)
Reports (54)
Research institute (2533)
Resumes & cover letters (369)
Rett syndrome (32)
RNA editing (18)
RSV (85)
Schizophrenia (175)
Series A (273)
Series B (206)
Service/supplier (11)
Sickle cell disease (110)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (46)
Startups (3842)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (97)
The Weekly (87)
Vaccines (1106)
Venture capital (102)
Weight loss (456)
Women's health (112)
Worklife (20)
Date
Last 7 days (653)
Last 30 days (2488)
Last 365 days (30716)
2026 (8199)
2025 (31062)
2024 (36180)
2023 (41103)
2022 (52372)
2021 (56934)
2020 (55468)
2019 (48274)
2018 (36443)
2017 (33805)
2016 (33424)
2015 (39431)
2014 (33316)
2013 (28351)
2012 (30501)
2011 (31171)
2010 (29287)
Location
Africa (838)
Alabama (90)
Alaska (7)
Arizona (341)
Arkansas (15)
Asia (43767)
Australia (7075)
California (12393)
Canada (3541)
China (1293)
Colorado (529)
Connecticut (529)
Delaware (372)
Europe (95089)
Florida (1885)
Georgia (396)
Hawaii (3)
Idaho (62)
Illinois (996)
India (85)
Indiana (571)
Iowa (22)
Japan (501)
Kansas (131)
Kentucky (44)
Louisiana (40)
Maine (85)
Maryland (1506)
Massachusetts (8931)
Michigan (358)
Minnesota (683)
Mississippi (6)
Missouri (149)
Montana (34)
Nebraska (29)
Nevada (136)
New Hampshire (83)
New Jersey (3305)
New Mexico (29)
New York (3276)
North Carolina (1637)
North Dakota (8)
Northern California (6100)
Ohio (371)
Oklahoma (23)
Oregon (46)
Pennsylvania (2513)
Puerto Rico (26)
Rhode Island (50)
South America (1216)
South Carolina (77)
South Dakota (1)
Southern California (4884)
Tennessee (199)
Texas (1958)
United States (44187)
Utah (373)
Vermont (1)
Virginia (310)
Washington D.C. (82)
Washington State (998)
West Virginia (4)
Wisconsin (128)
Wyoming (2)
761,033 Results for "samaritan pharmaceuticals inc formerly steroidogenesis inhibitors international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines
February 25, 2026
·
4 min read
Press Releases
Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
March 30, 2026
·
4 min read
Press Releases
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
February 2, 2026
·
4 min read
Press Releases
Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals
January 12, 2026
·
2 min read
Press Releases
KalVista Pharmaceuticals Announces Inclusion of EKTERLY® (sebetralstat) as a First-Line Therapy for Adolescents 12 and Older in International Pediatric HAE Guideline
February 18, 2026
·
8 min read
Press Releases
Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
February 19, 2026
·
6 min read
Press Releases
Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)
March 30, 2026
·
2 min read
Press Releases
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
March 13, 2026
·
13 min read
Press Releases
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
March 25, 2026
·
13 min read
Press Releases
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
March 25, 2026
·
3 min read
1 of 76,104
Next
